Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
Part of paid clinical trials in Bryant, Arkansas.
- Sponsor
- Bristol-Myers Squibb
- Study ID
- NCT07379827
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Xanomeline and trospium chloride (KarXT) — DRUGAccording to the product label
Study Details
The purpose of this study is to describe real-world treatment patterns, effectiveness and adverse events of adults diagnosed with schizophrenia that have initiated xanomeline and trospium chloride (KarXT) treatment in the United States
Key Dates
- Start date
- Feb 26, 2026
- Status verified
- Apr 2026
- Primary completion
- Jun 20, 2028
- Completion
- Jun 20, 2028
Study Design
- Enrollment
- 1,500 participants (estimated)
Arms
- Arm: Group 1Participants diagnosed with schizophrenia receiving xanomeline and trospium chloride (KarXT)
Primary Outcome Measure
Treatment titration and switch regimens as described by the prescribing clinician [ Time Frame: Baseline and up to 20 weeks ]
Central Contacts
- BMS Clinical Trials Contact Center www.BMSClinicalTrials.com855-907-3286
- First line of the email MUST contain NCT # and Site #.
Locations (45)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Local Institution - 0009 | Bryant | Arkansas | 72022 | Site 0009 |
| Local Institution - 0003 | Anaheim | California | 92805 | Site 0003 |
| Local Institution - 0039 | Chino | California | 91710 | Site 0039 |
| Local Institution - 0012 | La Palma | California | 90623 | Site 0012 |
| Local Institution - 0043 | Oceanside | California | 92056-4509 | Site 0043 |
| Local Institution - 0028 | Stanford | California | 94304 | Site 0028 |
| Local Institution - 0005 | Bonita Springs | Florida | 34134 | Site 0005 |
| Local Institution - 0019 | Hialeah | Florida | 33016-1814 | Site 0019 |
| Local Institution - 0030 | Homestead | Florida | 33030 | Site 0030 |
| Local Institution - 0029 | Kendall | Florida | 33186 | Site 0029 |
| Banyan Behavioal Care Program - CSU | Miami | Florida | 33134 | Moraima Trujillo, Site 0011 305-246-0001 |
| Local Institution - 0006 | Miami | Florida | 33175 | Site 0006 |
| Local Institution - 0007 | Miami | Florida | 33155 | Site 0007 |
| Local Institution - 0032 | Miami | Florida | 33015 | Site 0032 |
| Local Institution - 0023 | Orange City | Florida | 32763 | Site 0023 |
| Local Institution - 0040 | Orlando | Florida | 32803 | Site 0040 |
| Local Institution - 0025 | Atlanta | Georgia | 30303 | Site 0025 |
| Local Institution - 0044 | Marietta | Georgia | 30060 | Site 0044 |
| Local Institution - 0014 | Bloomfield Township | Michigan | 48302-1909 | Site 0014 |
| Local Institution - 0036 | Detroit | Michigan | 48203 | Site 0036 |
| Local Institution - 0034 | Apple Valley | Minnesota | 55124 | Site 0034 |
| Local Institution - 0041 | Lincoln | Nebraska | 68526-9474 | Site 0041 |
| Local Institution - 0037 | Buffalo | New York | 14215 | Site 0037 |
| Local Institution - 0004 | Monsey | New York | 10952 | Site 0004 |
| Local Institution - 0038 | Rochester | New York | 14623 | Site 0038 |
| Local Institution - 0020 | White Plains | New York | 10601 | Site 0020 |
| Local Institution - 0042 | Cary | North Carolina | 27513 | Site 0042 |
| PPD Virtual - PPD - US | Wilmington | North Carolina | 28401-3331 | Ghazaleh Bahrami, Site 0001 866-609-3139 |
| Local Institution - 0031 | Mason | Ohio | 45040-7846 | Site 0031 |
| Local Institution - 0027 | Oklahoma City | Oklahoma | 73112-8729 | Site 0027 |
| Local Institution - 0015 | Philadelphia | Pennsylvania | 19104-4238 | Site 0015 |
| Psychiatric Consultants, Pc | Franklin | Tennessee | 37607 | James Hart, Site 0002 615-807-4025 |
| Local Institution - 0016 | Austin | Texas | 78754 | Site 0016 |
| Local Institution - 0021 | Fort Worth | Texas | 76132 | Site 0021 |
| Local Institution - 0010 | Houston | Texas | 77054 | Site 0010 |
| Local Institution - 0022 | Houston | Texas | 77054-2852 | Site 0022 |
| Local Institution - 0024 | Houston | Texas | 77099 | Site 0024 |
| Local Institution - 0026 | Houston | Texas | 77008-1758 | Site 0026 |
| Local Institution - 0033 | Houston | Texas | 77007-9015 | Site 0033 |
| Local Institution - 0017 | Irving | Texas | 75062-2757 | Site 0017 |
| Local Institution - 0013 | McKinney | Texas | 75092 | Site 0013 |
| Local Institution - 0008 | Richmond | Texas | 77407-3498 | Site 0008 |
| Local Institution - 0035 | San Antonio | Texas | 78240 | Site 0035 |
| Local Institution - 0018 | Stafford | Texas | 77477-3954 | Site 0018 |
| Local Institution - 0045 | Petersburg | Virginia | 23805 | Site 0045 |
Find similar trials in Bryant, AR
By condition
By specialty
Related Studies
- Zyprexa® Relprevv™ Patient Care ProgramEnrolling By Invitation · Eli Lilly and Company · Blue Bell, Pennsylvania
- Database Registry for Neural Network Biomarkers in PsychosisRecruiting · University of Texas Southwestern Medical Center · Dallas, Texas
- Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as CorrelatesPHASE4 · Recruiting · Corporal Michael J. Crescenz VA Medical Center · Philadelphia, Pennsylvania
- Bromocriptine for Patients With Schizophrenia and PrediabetesPHASE4 · Not Yet Recruiting · VA Pittsburgh Healthcare System · Pittsburgh, Pennsylvania